Month: November 2022

On September 1, 2012, de Mesquita, Joao P.; Donnici, Claudio L.; Teixeira, Ivo F.; Pereira, Fabiano V. published an article.Recommanded Product: Methyl 6-chloro-6-oxohexanoate The title of the article was Bio-based nanocomposites obtained through covalent linkage between chitosan and cellulose nanocrystals. And the article contained the following:

Bio-based nanocomposites were obtained through covalent linkage between cellulose nanocrystals (CNCs) and the natural polymer chitosan (CH). The CNCs were first functionalized with Me adipoyl chloride (MAC) and the reactive end groups on the surface of the CNCs were reacted with the amino groups of the CH biopolymer in an aqueous medium. The functionalized CNCs and the resulting nanocomposites were characterized using FTIR, TEM, XRD, and elemental analyses. Characterization of the functionalized CNCs showed that up to 8% of the hydroxyl groups in the nanocrystals were substituted by the MAC residue. The covalent linkage between the CNCs and CH was confirmed by FTIR spectroscopy. The nanocomposites demonstrated a significant improvement in the mech. performance and a considerable decrease in the hydrophilicity relative to the neat chitosan. The approach used in this work can be extended to other natural polymers. The experimental process involved the reaction of Methyl 6-chloro-6-oxohexanoate(cas: 35444-44-1).Recommanded Product: Methyl 6-chloro-6-oxohexanoate

The Article related to bionanocomposite covalent linkage chitosan cellulose nanocrystal, Cellulose, Lignin, Paper, and Other Wood Products: Cellulose and other aspects.Recommanded Product: Methyl 6-chloro-6-oxohexanoate

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On December 31, 2010, Sagratini, Gianni; Angeli, Piero; Buccioni, Michela; Gulini, Ugo; Marucci, Gabriella; Melchiorre, Carlo; Poggesi, Elena; Giardina, Dario published an article.Name: (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate The title of the article was Synthesis and α1-adrenoceptor antagonist activity of tamsulosin analogues. And the article contained the following:

Tamsulosin [I, R = Et (II)] is the most utilized α1-adrenoceptor antagonist in benign prostatic hyperplasia therapy owing to its uroselective antagonism and capability in relieving both obstructive and irritative lower urinary tract symptoms. Here, homochiral analogs I (R = i-Pr, PhCH2, CF3CH2) and III (cis-dioxane ring) were synthesized and their influence on the affinity profile for α1-adrenoceptor subtypes evaluated. Benzyl analog I (R = PhCH2) displayed a preferential antagonist profile for α1A-than α1D-and α1B-adrenoceptors, and a 12-fold higher potency at α1A-adrenoceptors with respect to the α1B subtype, and may have improved uroselectivity compared to II. The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).Name: (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

The Article related to tamsulosin analog preparation adrenoceptor antagonist activity benign prostatic hyperplasia, Heterocyclic Compounds (More Than One Hetero Atom): Dioxanes and other aspects.Name: (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On February 29, 1980, Bird, C. W.; Latif, M. published an article.Synthetic Route of 38939-88-7 The title of the article was A new synthesis of 3H-phenoxazin-3-ones. And the article contained the following:

Nine 3H-phenoxazin-3-ones I (R = H, Me, CO2Me; R1 = H, Me; R2 = H, Me, Cl, CO2Me, OH), potential intermediates in actinomycin synthesis, were prepared by cyclization of the novel nitro ethers II. Thus, II (R = R1 = R2 = H) was treated with Zn dust and NH4Cl in aqueous MeOCH2CH2OMe, and the solution aerated to give 67% I (R = R1 = R2 = H). The aeration is required to reconvert the alc. product of the reduction to I. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Synthetic Route of 38939-88-7

The Article related to reductive cyclization nitrophenyl hydroxyphenyl ether, actinomycin potential synthon phenoxazinone, phenoxazinone, Heterocyclic Compounds (More Than One Hetero Atom): Oxazines and other aspects.Synthetic Route of 38939-88-7

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On June 30, 2021, Chen, Dong; Li, Shiqing; Wang, Jinhua; Gou, Tiantian; Zhang, Linfeng; Wang, Guixia; Kong, Xiangfei published an article.Safety of 2-Amino-4-chlorobenzoic acid The title of the article was Visible-Light-Mediated Synthesis of Rutaecarpine Alkaloids through C-N Cross-Coupling Reaction. And the article contained the following:

A visible-light-initiated cross-dehydrogenative-coupling amination is described, featuring metal- and photocatalyst-free, at room temperature, and using air as an oxidant. The reaction provides a facile approach for the synthesis of rutaecarpine and its derivatives The substrates with electron-withdrawing groups give higher yields than those with electron-donating groups, but the substituent position has a negligible influence on the yield. Using binaphthyl-diyl hydrogen phosphate and dibenzyl phosphate as catalysts both deliver satisfying yields. This straightforward light-driven strategy might be applicable to the synthesis of quinazolinone derivatives The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).Safety of 2-Amino-4-chlorobenzoic acid

The Article related to aniline benzamide cross dehydrogenation coupling amination oxidation photocatalyst light, quinazolinone alkaloid preparation, rutaecarpine preparation, Alkaloids: Alkaloids Containing Three Or More Nitrogen Atoms and other aspects.Safety of 2-Amino-4-chlorobenzoic acid

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On July 1, 2021, Yu, Zhiyong; Li, Pan; Xu, Beidi; Zhou, Yu; Pang, Wei; Wen, Qiaodong; Shi, Yongqiang; Sun, Zhao; Lv, Meng published a patent.SDS of cas: 1056264-66-4 The title of the patent was PD-L1 antagonist compound and application. And the patent contained the following:

The invention disclosed a kind of PD-L1 antagonist, its preparation method and application. The claimed PD-L1 antagonist is shown in structure I (L1 = -CRARB-, -C(O)-; L2,L3 = -(CRCRD)p, -(CRCRD)p-NRa-(CRCRD)q-, -(CRCRD)p-O-(CRCRD)q-, carbonyl; W1,W2 = CRL or N; R1 = H, halo, nitro, etc.; R2-R5 = cyano, C3-6 cycloalkyl, C1-6 alkyl, etc.; Cy = (un)substituted Ph or six member heteroaryl, etc.; T,A = (un)substituted C1-6 alkyl, alkylenecycloalkyl, alkyleneheterocycloalkyl, etc.; m,o = 0, 1-2 integers). The claimed compound is prepared via multiple steps (procedure given). The prepared compound can be used as PD-L1 antagonist for preventing or treating immune-related disorders. The experimental process involved the reaction of 2-Bromo-3-chloro-6-fluorobenzaldehyde(cas: 1056264-66-4).SDS of cas: 1056264-66-4

The Article related to pd l1 antagonist preparation immune disease treatment, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.SDS of cas: 1056264-66-4

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On December 20, 2019, Tang, Yanfeng; Wang, Chun; Ding, Xinyu; Ge, Ming; Hu, Yulin; Ni, Renjie; Liu, Weiqun; Zhang, Mengke; Shen, Lujie; Xu, Runsheng published a patent.Recommanded Product: 452-75-5 The title of the patent was Preparation of 4-chloro-7-methyl-1H-indazole. And the patent contained the following:

The invention discloses a preparation method of 4-chloro-7-methyl-1H-indazole, which has the advantages of simple operation and high reaction efficiency. The invention compound was prepared via formylation reaction of 4-chloro-2-fluorotoluene with N, N-dimethylformamide in the presence of diisopropylaminolithium and heterocyclization reaction of the product with hydrazine hydrate. The experimental process involved the reaction of 4-Chloro-2-fluorotoluene(cas: 452-75-5).Recommanded Product: 452-75-5

The Article related to preparation chloro methyl indazole formylation heterocycle, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.Recommanded Product: 452-75-5

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On June 30, 2005, Honda, Aki; Suzuki, Koji published a patent.Recommanded Product: 4569-86-2 The title of the patent was Fluorescent assay for measuring environmental allergens using immobilized fluorogenic or chromogenic substrate for protease. And the patent contained the following:

A method and an apparatus for measuring environmental allergens without resort to an anti-allergen antibody, are provided. The method comprises measuring the protease activity of the allergen using a fluorogenic or chromogenic substrate immobilized on a support. Amide conjugates of Leu or Met with cresyl violet, safranine O, methylene violet 3RAX were used to measure aminopeptidase M activity of Mite dermatophagoides farinae and Cedar Pollen-Cj Japanese Cedar. Boc-Val-Leu-Lys-MCA, Leu-MCA, Met-MCA, Boc-Gln-Ala-Arg-MCA, Boc-Val-Leu-Lys-MCA, Bz-Arg-MCA, Glt-Ala-Ala-Phe-MCA, were also used. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Recommanded Product: 4569-86-2

The Article related to environment allergen immobilized fluorogenic chromogenic substrate, Biochemical Methods: Other (Not Covered At Other Subsections) and other aspects.Recommanded Product: 4569-86-2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Ukrainets, Igor V.; Petrushova, Lidiya A.; Shishkina, Svitlana V.; Sidorenko, Lyudmila V.; Alekseeva, Tatiana V.; Torianyk, Inna I.; Davidenko, Alexandra A. published an article in 2020, the title of the article was Methyl4-hydroxy-2,2-dioxo-1H-2λ6,1-benzothiazine-3-carboxylate and its analogs modified in the benzene moiety of the molecule as new analgesics.Computed Properties of 89-77-0 And the article contains the following content:

In order to identify new regularities of the “structure-analgesic activity” relationship in the series of 2,1-benzothiazine derivatives, the synthesis of Me 4-hydroxy-2,2-dioxo-1H-2λ 6,1-benzothiazine-3-carboxylates I [R = H, 7-Cl, 6,8-di-Br, etc.] and a group of its analogs substituted in the benzene moiety of the mol., as well as their mono-and diammonium salts, was performed with tris(hydroxymethyl)aminomethane. The algorithm was proposed; it allowed for uniquely solving the question of the nature of the substituent and its true position in the benzothiazine core based on the complex use of NMR (1H and 13C) and mass spectrometry data. Using single-crystal X-ray diffraction anal. it was proven that salt formation first passed through the cyclic sulfamide group and only then through the 4-hydroxyl group and was always accompanied by a significant conformational rearrangement of the mol. Based on the results of pharmacol. tests it was found that modification of the benzene moiety of the mol. could be used as a method for enhancing the analgesic properties of the class of compounds studied. The presence of a substitute in position 7 was particularly effective, regardless of its nature. A comparative anal. of the analgesic activity of the initial esters and their mono- and diammonium salts convincingly showed that the common belief about a direct relationship between the solubility of a substance and the level of its biol. effect was not always true. As it turned out, increasing the solubility in water could lead to a variety of consequences: From a significant increase in analgesia to its complete elimination. It was suggested that the analgesic activity of the compounds studied was determined not by solubility, but by the mol. conformations formed during their obtainment. The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).Computed Properties of 89-77-0

The Article related to methyl hydroxy dioxo benzothiazine carboxylate preparation analgesic, Heterocyclic Compounds (More Than One Hetero Atom): Thiazines and other aspects.Computed Properties of 89-77-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On March 15, 2016, Ji, Haitao; Yu, Binxun; Zhang, Min; Guo, Wenxing published a patent.SDS of cas: 38939-88-7 The title of the patent was Substituted 1h-indazol-1-ol analogs as inhibitors of beta catenin/tcf protein-protein interactions. And the patent contained the following:

In one aspect, the invention relates to substituted 1H-benzo[d][1,2,3]triazol-1-ol analogs, derivatives thereof, and related compound; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating disorders, e.g. various tumors and cancers, associated with β-catenin/Tcf protein-protein interaction dysfunction using the compounds and compositions This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).SDS of cas: 38939-88-7

The Article related to substituted indazole preparation beta catenin tcf protein interaction, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.SDS of cas: 38939-88-7

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On August 15, 2013, Ji, Haitao; Yu, Binxun; Zhang, Min; Guo, Wenxing published a patent.COA of Formula: C7H6ClNO2 The title of the patent was Preparation of substituted 1H-indazol-1-ol analogs as inhibitors of beta-catenin/Tcf protein-protein interactions. And the patent contained the following:

The invention relates to substituted 1H-benzo[d][1,2,3]triazol-1-ol analogs of formula I, synthetic methods for making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders, e.g. various tumors and cancers, associated with β-catenin/Tcf protein-protein interaction dysfunction using the compounds and compositions Compounds of formula I wherein A1 is N, NH and CR2a; A2 is N, CO, CS and CR2b; A3 is NOH and O; L is CH2, CH2CH2, CH2CH2CH2, OCH2, NHCH2, etc.; B1 is N, O and S; B2 is N, CO, CS, and SO; R11, R1b and R1c are independently H, halo, OH, NH2, C1-3 alkyl, etc.; R2a and R2b are independently H, halo, OH, NH2, C1-3 haloalkyl, etc.; and pharmaceutically acceptable salts, esters, hydrates, solvates, or polymorphs thereof, are claimed. Example compound II was prepared by a multistep procedure (procedure given). The invention compounds were evaluated for their inhibitory activity of β-catenin/Tcf protein-protein interaction. From the assay, it was determined that compound II exhibited Ki value of 1304 ± 2.03 μM. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).COA of Formula: C7H6ClNO2

The Article related to substituted indazole preparation beta catenin tcf protein interaction, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.COA of Formula: C7H6ClNO2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics